Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

02 Dec 2019

David Sanders joins Results and leads expansion in Care Services

We are delighted to announce that David Sanders joined Results International Group as a Managing Director in the Results Healthcare…

22 Nov 2019

Outsourced Pharmaceutical Manufacturing 2020

Outsourced Pharmaceutical Manufacturing 2020: Current trends & future prospects In our latest analysis of the commercial and clinical contract manufacturing…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

13 Jan 2020 - 09:00

J.P. Morgan 38th Healthcare Conference 2020

For four days during January every year, there is a distinct buzz that permeates the streets of San Francisco as…

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office